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Abstract We aimed to explore the combined contribution
of pre-surgical depression and anxiety symptoms for
recovery following coronary artery bypass graft (CABG)
using data from 251 participants. Participants were asses-
sed prior to surgery for depression and anxiety symptoms
and followed up at 12 months to assess pain and physical
symptoms, while hospital emergency admissions and
death/major adverse cardiac events (MACE) were moni-
tored on average 2.68 years after CABG. After controlling
for covariates, baseline anxiety symptoms, but not
depression, were associated with greater pain (b = 0.231,
p = 0.014) and greater physical symptoms (b = 0.194,
p = 0.034) 12 months after surgery. On the other hand,
after controlling for covariates, baseline depression symp-
toms, but not anxiety, were associated with greater odds of
having an emergency admission (OR 1.088, CI
1.010–1.171, p = 0.027) and greater hazard of death/
MACE (HR 1.137, CI 1.042–1.240, p = 0.004). These
findings point to different pathways linking mood symp-
toms with recovery after CABG surgery.
Keywords Depression  Anxiety  Coronary artery bypass
graft surgery  Recovery  Major adverse cardiac events 
Pain  Longitudinal study
Abbreviations
ARCS study Adjustment and recovery after cardiac
surgery study
BDI Beck depression inventory
BMI Body mass index
CABG Coronary artery bypass graft
CI Confidence intervals
EuroSCORE European system for cardiac operative risk
evaluation
HADS Hospital anxiety and depression scale
HR Hazard ratio
OR Odds ratio
Introduction
Co-morbid depression is commonly observed in patients
suffering from coronary heart disease (Dickens 2015). Two
landmark studies documented the impact of depression on
survival following coronary artery bypass graft (CABG)
surgery. Blumenthal and colleagues (Blumenthal et al.
2003) recruited 817 patients awaiting CABG and followed
participants up for an average of 5.2 years. They found that
patients with depression before CABG had increased risk
of death from all causes compared with those without
depression. Connerney and colleagues (Connerney et al.
2001) used standard diagnostic interviews in 309 patients
in the days following CABG, assessing both current and
history of depression. Patients were followed up at six and
12 months. They found that depression experienced after
CABG was an independent risk factor for cardiac events
after controlling for other risk factors including disease
severity. A recent population study has also corroborated
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the effect of depression before CABG (Stenman et al.
2014) on mortality.
Pre- and post-operative depression symptoms have been
shown to affect other indicators of recovery after CABG
surgery. For example, Burg and colleagues (Burg et al.
2003) found that patients who were depressed prior to
CABG had higher levels of medical complications during
the six months following surgery, and were more likely to
report poor quality of life and worse recovery. We recently
reported that pre-operative depression symptoms were
associated with longer post-operative hospital stays (Poole
et al. 2014) following CABG surgery. Depressive symp-
toms following CABG have been associated with graft
disease progression (Wellenius et al. 2008) and hospital
readmissions (Tully et al. 2008). In addition, post-operative
depression symptoms have been associated with poorer
functional recovery such as shorter walking distances
(Doering et al. 2005) and poorer physical recovery
including more infections and impaired wound healing
(Doering et al. 2005, 2008) in CABG patients.
A few studies have also implicated anxiety in predicting
poorer prognosis in CABG patients. Tully and colleagues
(Tully 2008) found that patients with higher levels of
anxiety prior to CABG were at greater risk of mortality;
these findings have been corroborated more recently (Tully
et al. 2015). Another study has also confirmed the effect of
anxiety following CABG on mortality (Rosenbloom et al.
2009), and Oxlad and colleagues showed anxiety in the
immediate post-operative period was associated with
greater hospital readmissions six months after CABG
(Oxlad et al. 2006).
To date, only three studies have examined the combined
effects of depression and anxiety symptoms in CABG
patients to assess the relative importance of these mood
disorders on recovery. However, there have been mixed
findings. The first found pre-operative depression symp-
toms, but not anxiety symptoms, to predict poor health
related quality of life in 193 participants followed up six
months after surgery (Tully et al. 2009). The second
included 158 CABG patients and found pre-operative
generalised anxiety disorder, but not major depression,
predicted major adverse cardiovascular and cerebrovascu-
lar events (Tully et al. 2015). The third found post-opera-
tive anxiety, but not depression symptoms, to predict major
adverse events and mortality up to four years following
surgery in a sample of 180 CABG patients (Sze´kely et al.
2007). Therefore, it is not yet clear to what extent anxiety
symptoms predict cardiac morbidity and mortality over and
above depression symptoms or vice versa.
Since measures of mood are likely to be influenced by
acute feelings of anticipation leading up to the surgical
procedure, we chose to study the independent effects of
depression and anxiety symptoms measured a month prior
to surgery. In addition, in order to shed some light on the
discrepant findings surrounding the role of depression and
anxiety on later recovery, we assessed multiple recovery
endpoints. Specifically, this study sought to explore the
effects of pre-operative depression and anxiety symptoms
on physical recovery following CABG to include sensory
pain and physical symptom reporting, and emergency
department admissions, and major adverse cardiac events
(MACE) and/or death following CABG surgery.
Method
Participants
The study uses data collected in the Adjustment and
Recovery after Cardiac Surgery (ARCS) Study (Poole et al.
2014a; Steptoe et al. 2015). Participants included in these
analyses are the 251 CABG surgery patients (mean age:
67.91 ± 8.85 years, 13.1 % females) who provided com-
plete data and who were recruited from a pre-surgery
assessment clinic at St. George’s Hospital, London. The
power analysis for this study was based on the paper by
Connerney and colleagues (Connerney et al. 2001) and
calculated using nQuery Advisor 4.0. Based on their find-
ings an association of depression with clinical cardiac
outcomes would be detected at 80 % power (two sided test,
p\ 0.05) with 64 patients with high and low depression
scores. Using data from our pilot study we estimated a
prevalence of 30 % of cases with high depression scores on
the BDI prior to surgery, indicating a sample size of at least
213 would be needed to detect a significant effect on death/
MACE. While ARCS was not specifically powered to
assess anxiety, using data from Szekely et al. (Sze´kely
et al. 2007) an association of anxiety with clinical cardiac
outcomes would be detected at 80 % power (two sided test,
p\ 0.05) with 56 patients with high and low anxiety
scores. Using data from our pilot study we estimated a
prevalence of 25 % of cases with high anxiety scores on
the HADS prior to surgery, indicating a sample size of at
least 224 would be needed to detect a significant effect on
death/MACE. Since our analyses were powered to inves-
tigate death/MACE, our analyses using the alternative
outcomes are exploratory in nature.
Compared to the participants who were included in these
analyses, the included participants were more likely to be
male (x2 = 6.867, p = 0.008) and have one or more
comorbidities (x2 = 46.055, p\ 0.001), but otherwise did
not differ on any other clinical or demographic variable.
The baseline assessment took place on average 30 days
before patients’ surgery and included measures of depres-
sion and anxiety symptoms and demographic measures
completed by postal questionnaire. The follow-up assess-
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ment of self-reported outcomes, i.e. pain and symptom
reporting, took place on average 397 days after CABG also
by postal questionnaire. Clinical outcomes, i.e. death/
MACE and emergency department admissions were col-
lected on average 2.68 years (range: 1.84–3.44 years) after
CABG. Inclusion criteria permitted only patients who were
undergoing elective CABG surgery or CABG plus valve
replacement to participate. CABG surgery included both
on-pump and off-pump surgical procedures. In addition,
participants had to be able to complete the questionnaires
in English, and be 18 years or older. All procedures were
carried out with the written consent of the participants.
Ethical approval was obtained from the South West Lon-
don research ethics committee.
Measures
Predictor variables: depression and anxiety
The Beck Depression Inventory (BDI) (Beck et al. 1988)
was used to measure depression symptoms at baseline. It is
a 21-item questionnaire which asks the respondent to
reflect on how they have been feeling over the past two
weeks. Ratings were summed, with higher scores indicat-
ing greater emotional disturbance, with a range of 0–63
(Cronbach’s a = 0.85). For illustration purposes, we used
a standard cut-off of\/C10 to indicate no depression and
mild to severe depression respectively.
The Hospital Anxiety and Depression Scale (HADS) is a
self-report measure of anxiety and depression for use in
outpatient clinical settings (Zigmond and Snaith 1983).
Only the 7-item anxiety scale was administered at baseline,
capturing the extent to which each symptom has been
experienced over the past two weeks. Items were summed
to generate an overall score, with higher scores indicating
greater anxiety (Cronbach’s a = 0.88).
Outcome variables: pain, physical symptoms, emergency
department admissions, death/MACE
The McGill Pain Questionnaire-Short Form (MPQ-SF)
(Melzack 1987) was developed as a brief version of the
standard MPQ and is suitable for use in post-surgical
patients. This measure was administered 12 months post-
CABG. The sensory pain score was used here and reflects
the sum of the intensity values for the sensory descriptor
words (throbbing, aching, stabbing etc.). Higher scores
indicate greater pain (sensory pain Cronbach’s a = 0.91).
The Coronary Revascularisation Outcomes Question-
naire (CROQ) (Schroter and Lamping 2004) was designed
to assess quality of life and health outcomes following
cardiac surgery. This study used the adverse effects sub-
scale from the version adapted for CABG surgery and was
administered 12 months after surgery. Patients were asked
to rate the extent to which they had experienced a series of
physical symptoms related to their surgery such as bruis-
ing, numbness and tingling and swelling, using a 5-point
Likert scale ranging from 0 (Not at all) to 4 (A lot); higher
scores indicate greater negative symptoms (Cronbach’s
a = 0.81).
Post-operative MACE included admissions for
myocardial infarction, unstable angina, stroke, and/or heart
failure. Occurrence of MACE or death were combined to
create a binary variable. Emergency department admissions
were also categorised into no admissions or C1 admission.
Mortality, MACE and emergency department admission
data were gathered by reviewing in-hospital electronic and
paper patient records.
Covariates: clinical and sociodemographic measures
Cardiovascular history, clinical factors during admission
and management were also obtained from clinical notes.
Clinical risk was assessed using the European System for
Cardiac Operative Risk Evaluation (EuroSCORE) (Roques
et al. 2003). EuroSCORE is a composite measure of pro-
cedural mortality risk based on 17 factors comprising
patient-related factors (e.g. age, sex), cardiac-related fac-
tors (e.g. unstable angina, recent MI) and surgery-related
factors (e.g. surgery on thoracic aorta). Items were scored
in accordance with the ‘logistic EuroSCORE’ method to
generate a percentage mortality risk estimate; further
details of the scoring method can be found on the Euro-
SCORE website (www.euroscore.org/logisticEuroSCORE.
htm) Goldstone (n.d.). In addition, the number of grafts a
participant received and whether they underwent car-
diopulmonary bypass (yes/no) were also recorded. History
of diabetes was also taken from medical notes.
Participants were asked about any longstanding illnesses
prior to surgery; responses were counted to compute a
chronic illness burden variable to capture the number of
illnesses a participant had in addition to their coronary
artery disease. Participants also self-reported use of medi-
cations to include the use of antidepressants and anxiolyt-
ics. Smoking was measured as a binary variable at baseline
(current smoker/non-smoker). Body mass index (BMI) was
assessed at the pre-operative clinic appointment and cal-
culated using the standard formula (kg/m2).
Statistical analysis
Missing data (n = 75) on the self-reported outcomes meant
that some analyses were performed on a reduced sample
size. Of all participants, sensory pain and CROQ scores
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were available for 176 participants. Descriptive statistics
describe the 251 participants who provided full baseline
and clinical outcome data. Associations between variables
were assessed using Pearson’s correlations for continuous
data and independent t-tests or Chi-square tests for cate-
gorical variables. The predictor variables, depression and
anxiety symptoms, were entered simultaneously into
models since the assumption of no mulitcollinearity was
not violated. Similar findings were found entering depres-
sion and anxiety symptoms separately into models. To test
the association between baseline depression and anxiety
symptoms on sensory pain and physical symptom reporting
(CROQ), we used multiple linear regression analyses. We
controlled for several potential confounders of the associ-
ations, namely BMI, smoking status, diabetes, chronic ill-
ness burden, use of cardiopulmonary bypass, EuroSCORE,
and use of antidepressants and anxiolytics. Age and sex are
included in EuroSCORE so were not entered separately to
avoid double adjustment. The association between depres-
sion and anxiety symptoms and emergency department
admissions were modelled using logistic regressions.
Results are presented as adjusted odds ratios (OR) with 95 %
confidence intervals (CI). The association between depres-
sion and anxiety symptoms and death/MACE were modelled
using Cox proportional hazards regressions. The assumption
of proportional hazards was upheld in all the models. Results
are presented as adjusted hazard ratios (HR) with 95 % CI.
Due to the small event rate in the emergency department
admission and death/MACE analyses, we only controlled for
EuroSCORE and chronic illness burden in these analyses to
avoid over-fitting the model. We illustrated the significant
associations by comparing the risk of death/MACE in
patients with low/high depression (BDI\/C10), after
adjustment for covariates. Secondary analyses were per-
formed for all models in which the mean-centred depression-
anxiety symptom interaction term was included as a
covariate. No significant interactions were found so the
results are not reported here. All analyses were conducted
using SPSS version 21. Two-tailed tests were used
throughout and the significance level was set at p\ 0.05,
though exact significance levels are reported.
Results
Descriptive characteristics of the sample are displayed in
Table 1. The majority of participants were male (87.0 %),
overweight (BMI[25 = 82.5 %) and of White ethnic ori-
gin (88.0 %). Predicted mortality risk according to Euro-
SCORE ranged from 1.5 % to 22.0 %. Comorbidities were
common, particularly diabetes which was present in a quarter
of participants and hypertension (79.3 %). The majority of
participants underwent on-pump surgery in isolation.
Depression and anxiety symptoms were prevalent at base-
line. Over a third (35.9 %) of participants reported moderate
to severe depression symptoms (BDI scores C10) and just
under a third of participants (31.9 %) reported anxiety
symptoms within the mild to severe range (HADS score C8).
Depression and anxiety symptoms were significantly corre-
lated (r = 0.641, p\ 0.001). Twelve-months following
CABG surgery approximately half (48.9 %) of participants
were still experiencing some pain, and 90.3 % had physical
symptoms relating to their surgery. Sensory pain and phys-
ical symptom reporting were positively correlated
(r = 0.690, p\ 0.001). With regards to the clinical out-
comes there were 19 death/MACE events of which 9 par-
ticipants died, 8 participants experienced a MACE, and a
further 2 participants experienced both MACE and death.
Table 1 Demographic, clinical and mood characteristics of the
sample (N = 251)
Characteristic Mean ± SD or N
(%)
Demographics
Age (years) 67.91 ± 8.85
Female 33 (13.1)
BMI (kg/m2) 28.84 ± 4.33
Married/cohabiting 196 (75.7)
Ethnicity–white British/other white 221 (88.0)
Smoker 20 (8.0)
Co-morbidities
Chronic illness burden 0.47 ± 0.65
Diabetes 63 (25.0)
Hypertension 199 (79.3)
Pulmonary disease 18 (7.2)
Neurological disorder 19 (8.0)
Extracardiac arteriopathy 22 (8.8)
Clinical factors
Logistic EuroSCORE (%) 4.52 ± 3.24
MI\30 days prior to CABG 1 (\0.0)
CABG in isolation 191 (76.1)
Number of grafts 2.96 ± 1.12
On-pump 200 (79.7)
Sensory pain (MPQ-SF) 12-months post-CABG 1.75 ± 3.74*
Physical symptoms (CROQ) 12-months post-
CABG
5.68 ± 5.50*
Emergency department admissions C1 23 (9.2)
Death/MACE C1 19 (7.6)
Mood factors
Baseline BDI score 8.62 ± 6.57
Baseline HADS-anxiety score 5.96 ± 4.30
Antidepressant use 14 (5.6)
Anxiolytic use 2 (0.8)
* N = 176
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Baseline depression and anxiety symptoms
predicting pain and physical symptoms 12 months
after CABG
Table 2 displays the regression model examining the
prospective association between pre-operative depression
and anxiety symptoms and sensory pain measured
12 months after CABG surgery. The results show that
greater anxiety symptoms were associated with greater
post-operative pain (b = 0.215, p = 0.023), after control-
ling for covariates. Baseline depression was not a signifi-
cant predictor in this model. The model accounted for
8.5 % of variance in sensory pain.
Table 3 displays the regression model examining the
prospective association between pre-operative depression
and anxiety symptoms and physical symptoms measured
12 months after CABG surgery. The results show that
greater anxiety symptoms were associated with greater
physical symptoms (b = 0.191, p = 0.035), after control-
ling for covariates. Baseline depression was not a signifi-
cant predictor in this model. The model accounted for
15.1 % of variance in physical symptoms.
Baseline depression and anxiety symptoms
predicting clinical outcomes after CABG
Table 4 displays models showing the relationship between
baseline depression and anxiety measures and post-operative
emergency department admissions. The results show that
after controlling for chronic illness burden and EuroSCORE,
a 1-point increment on the BDI was associated with an 8.8 %
increase in the risk of having an emergency department
admission (OR 1.088, CI 1.010-1.171, p = 0.027). Anxiety
symptoms were not significantly associated with increased
risk of emergency department admissions.
Table 5 shows the results from the Cox regression
model for depression and anxiety symptoms predicting
death/MACE following CABG. Results show that a 1-point
increment on the BDI was associated with a 13.7 %
increased hazard of death/MACE after controlling for
covariates (HR 1.137, CI 1.042–1.240, p = 0.004). Anxi-
ety symptoms were not significant predictors in this model.
This association is illustrated in Fig. 1, showing the risk of
death/MACE in patients with low/high depression (BDI\/
C10), after adjustment for covariates.
Table 2 Multiple regression showing baseline anxiety predicting sensory pain (N = 176)
Model B SE b 95 % CI p
Baseline BDI score 0.065 0.059 0.105 -0.052–0.183 0.272
Baseline HADS-anxiety score 0.192 0.083 0.215 0.027–0.356 0.023
BMI -0.051 0.073 -0.054 -0.194–0.093 0.487
Smoker -1.207 1.161 -0.082 -3.499–1.085 0.300
Diabetes 0.582 0.956 0.064 -1.306–2.469 0.544
Chronic illness burden 0.902 0.617 0.154 -0.315–2.119 0.145
Cardiopulmonary bypass -0.598 0.691 -0.064 -1.963–0.766 0.388
EuroSCORE -0.074 0.094 -0.061 -0.259–0.111 0.431
Baseline anxiolytic use -0.570 2.681 -0.016 -5.863–4.723 0.832
Baseline antidepressant use 2.121 1.320 0.125 -0.486–4.727 0.110
Table 3 Multiple regression showing baseline anxiety predicting physical symptoms (N = 176)
Model B SE b 95 % CI p
Baseline BDI score 0.149 0.083 0.164 -0.015–0.313 0.075
Baseline HADS-anxiety score 0.247 0.117 0.191 0.017–0.478 0.035
BMI 0.134 0.102 0.098 -0.066–0.335 0.188
Smoker -0.939 1.625 -0.044 -4.148–2.269 0.564
Diabetes -0.454 1.338 -0.034 -3.097–2.188 0.735
Chronic illness burden 2.069 0.863 0.243 0.365–3.773 0.018
Cardiopulmonary bypass 0.410 0.967 0.030 -1.500–2.319 0.673
EuroSCORE 0.103 0.131 0.058 -0.156–0.363 0.432
Baseline anxiolytic use -8.039 3.753 -0.157 -15.448–0.629 0.034
Baseline antidepressant use 4.554 1.848 0.185 0.905–8.203 0.015
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Discussion
This study sought to examine the effects of depression and
anxiety on surgical recovery in a sample of patients
undergoing first-time, elective CABG. Depression and
anxiety were entered simultaneously into models in order
to ascertain the effect of depression over and above anxiety
(and vice versa) on predicting recovery. We showed that
pre-operative anxiety predicted the self-reported outcomes,
sensory pain and physical symptoms 12 months after sur-
gery, while pre-operative depression predicted the objec-
tive outcomes, emergency department admission and
death/MACE in the years after surgery.
Our findings can be interpreted in light of previous research
in this field. Multiple studies have shown depression prior to
CABG to be a significant predictor of morbidity and mortality
in the months and years following surgery (Blumenthal et al.
2003; Burg et al. 2003; Burg et al. 2003), and similar effects
have also been observed for anxiety (Tully et al. 2008; Tully
et al. 2015). Interestingly in our study we found that anxiety
symptoms predicted the self-reported measures whereas
depression symptoms predicted the objective measures.
Table 4 Logistic regression showing baseline depression predicting emergency department admissions (N = 251)
Model OR 95 % CI p
Baseline BDI score 1.088 1.088–1.171 0.027
Baseline HADS-anxiety score 1.003 1.003–1.171 0.966
Chronic illness burden 1.193 1.193–2.309 0.601
EuroSCORE 1.087 1.087–1.221 0.158
Table 5 Cox regression showing baseline depression predicting death/MACE (N = 251)
Model HR 95 % CI p
Baseline BDI score 1.137 1.042–1.240 0.004
Baseline HADS-anxiety score 0.871 0.748–1.013 0.073
Chronic illness burden 1.609 0.859–3.016 0.138
EuroSCORE 1.231 1.113–1.361 \0.001
Fig. 1 Death/MACE by depression severity status on the BDI; fully adjusted model (N = 251)
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We surmise that in our study greater anxiety symptoms
increased the likelihood of patients being hypervigilant to
somatic symptoms long after the acute phase of recovery
had passed. Previous work has supported the association
between anxiety and over-reporting of somatic symptoms
(Hoehn-Saric et al. 2004). Indeed, health anxiety has a
lifetime prevalence of approximately 5.7 % (Sunderland
et al. 2013) and is a well-established contributing factor to
somatosensory amplification (Barsky and Wyshak 1990).
Health anxiety has been found to detrimentally affect
wellbeing, quality of life and use of healthcare services
(Asmundson et al. 2010; Barsky et al. 2001), but is
responsive to cognitive behaviour therapy (Tyrer et al.
2014). A meta-analysis investigating the association of
depression and anxiety with medical symptom reporting
suggests that both depression and anxiety were at least as
strongly associated with somatic symptoms as objective
physiological measures of illness (Katon et al. 2007). In
addition, Katon proposes that depression and anxiety pre-
vent habituation to the symptoms of physical illnesses,
such as pain (Katon 2003). In our study, we did not support
the role of depression symptoms on symptom burden,
perhaps because unlike the studies cited above, we con-
sidered depression and anxiety simultaneously in models.
In our study we also found individuals with greater
depression symptoms were more likely to experience a
verifiable clinical episode. These results suggest a different
mechanism was in operation in those with depression
symptoms compared to those with anxiety symptoms.
Multiple mechanisms have been proposed linking depres-
sion to adverse events in cardiac patients including bio-
logical, social and behavioural factors. We have previously
shown that heightened C-reactive protein levels in response
to CABG surgery mediated the association between
depression and longer hospital stays (Poole et al. 2014b). In
addition we have also shown that greater interferon-gamma
responses to surgery were associated with increased risk of
depression 12 months after CABG surgery (Steptoe et al.
2015). Therefore, inflammation presents one possible
pathway linking depression and greater adverse events in
our sample. We have also shown that social factors such as
low socioeconomic status (Poole et al. 2014) and beha-
vioural factors such as sleep (Poole et al. 2014a) are also
important for outcomes in CABG patients. Medication
non-adherence could also be another explanatory factor,
since depressed patients have been shown to be less
adherent to cardiac medications than their non-depressed
counterparts (Rieckmann et al. 2006, 2011). It is possible
that depression and anxiety symptoms differentially
affected recovery in the ARCS participants by operating
along different mechanistic pathways. More work would be
needed to tease out the exact causes of these effects using a
larger sample of participants.
We considered depression and anxiety simultaneously in
models, which we believe a more ecologically valid
approach. Depression and anxiety often present as co-
morbid conditions, which may partly be explained by the
common symptom criteria for both disorders. Theories
have been proposed in which anxiety and depressive dis-
orders should be viewed collectively as part of a higher-
order diagnosis of negative affectivity, characterised by
heightened levels of distress, negative emotionality and
neuroticism (Andrews et al. 2009; Brown and Barlow
2009; Prenoveau et al. 2010; Watson 2009). However, a
recent paper by Tully found that a clinical diagnosis of
generalised anxiety disorder was the best predictor of
MACE after CABG surgery than other classifications of
mood disorders and negative affect symptom clusters
(Tully et al. 2015). In a sample of patients with
stable coronary artery disease, Frasure-Smith and Les-
pe´rance (2008) reported that patients with comorbid ele-
vated anxiety and depression symptoms were not at
elevated risk of MACE, compared to those with one con-
dition alone. In contrast, we found depression symptoms,
but not anxiety symptoms to predict death/MACE after
CABG surgery. The discrepancy between ours and Tully’s
findings could partly be explained by the difference in the
sample. We recruited first-time, elective CABG patients to
the ARCS study whereas Tully and colleagues also inclu-
ded emergency patients. This difference in demographic is
reflected in the number of previous myocardial infarctions
experienced by participants. Only one of our participants
experienced a myocardial infarction in the month preced-
ing surgery compared with just over one-third of partici-
pants in the Tully study. Therefore there are likely
differences between our studies regarding the extent to
which anxiety brought on by this major adverse cardiac
event was captured.
Our findings are thought to be clinically relevant since
intervention studies could help ameliorate negative mood
symptoms in CABG patients. Intervention studies designed to
improve emotional wellbeing have generally focussed on
post-CABG depression, and have shown mixed results. Pos-
itive results were found by Freedland and colleagues
(Freedland et al. 2009) who conducted a 12 week randomised
controlled trial to assess the efficacy of two different types of
non-pharmacological treatment for depression symptoms after
CABG, in comparison to usual care controls. Results showed
significantly higher rates of remission in depressed patients
who received cognitive behavioural therapy or supportive
stress-management compared to usual care controls, at three-
and nine-month follow-up. The Bypassing the Blues ran-
domised controlled trial, investigated the impact of a tele-
phone delivered collaborative care intervention in post-
CABG depressed patients, compared to usual care depressed
controls and non-depressed controls. The intervention group
J Behav Med (2017) 40:249–258 255
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received a tailored nurse-led telephone delivered programme
for up to eight months following CABG. Results showed
significant improvements in health-related quality of life and
mood in the intervention group compared to usual care con-
trols, however the effect was stronger for men than women
(Rollman et al. 2009; Rollman and Herbeck Belnap 2011).
Despite these studies demonstrating a positive impact on
emotional wellbeing, three other randomised controlled trials
have been less conclusive (Furze et al. 2009; Lie et al. 2007;
Sebregts et al. 2005). As yet no trials have shown treatment of
depression translates to improved clinical outcomes; however,
positive effects were reported in the SUPRIM study (Gul-
liksson et al. 2011) of stress management and these findings
could potentially inform future depression trials. In addition,
more work is needed to assess the benefits of treating
depression and anxiety prior to surgery.
There are several strengths and weakness to our study.
In terms of strengths, the longitudinal design of the ARCS
study allows for the temporal relationship between
depression, anxiety and surgical recovery to be analysed.
Moreover, our collection of both self-reported and clinical
endpoints has allowed us to assess several indicators of
recovery. Baseline assessments of mood took place a
month prior to surgery, minimising the effects of acute
distress in the anticipation of major surgery. In addition,
the ARCS study examined patients undergoing CABG at a
single hospital and therefore removes the influence of inter-
hospital variation in patient care. There are also some
weakness that must be borne in mind. Firstly, we have
relied on questionnaire measures of mood, which restricts
us from generalising our results to clinically depressed and
anxious samples. The validity of the HADS has recently
been questioned, with concerns regarding its latent struc-
ture (Cosco et al. 2012; Coyne and van Sonderen 2012).
However, others have found in favour of its suitability, and
it has just been listed as among the acceptable measures for
screening for depression in adults described by the US
Preventive Services Task Force (Siu et al. 2016). The
HADS-anxiety score was used as a continuous measure in
our models to sidestep the issue of caseness. Secondly, we
only had a small number of death/MACE clinical events in
our study so were unable to control for a wide range of
clinical and demographic confounders in the analyses. The
findings we have reported may have clinical implications
regarding the screening and management of depression and
anxiety in a CABG population.
In conclusion, we found that greater pre-CABG anxiety
symptoms were associated with poorer self-reported out-
comes 12 months after surgery, including greater pain and
physical symptoms. On the other hand, greater pre-CABG
depression symptoms were associated with the objective
clinical outcomes: death/MACE and emergency depart-
ment admissions in the years following surgery. Further
work is needed to delineate the pathways of these effects
and the most appropriate treatment strategies.
Acknowledgments This research was funded by the British Heart
Foundation.
Compliance with ethical standards
Conflict of interest Lydia Poole, Amy Ronaldson, Tara Kidd, Eliz-
abeth Leigh, Marjan Jahangiri and Andrew Steptoe declare that they
do not have any conflict of interest.
Human and animal rights and Informed consent All procedures
followed were in accordance with ethical standards of the responsible
committee on human experimentation (institutional and national) and
with the Helsinki Declaration of 1975, as revised in 2000. Informed
consent was obtained from all patients for being included in the study.
Open Access This article is distributed under the terms of the Creative
Commons Attribution 4.0 International License (http://creativecommons.
org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the
original author(s) and the source, provide a link to the Creative Com-
mons license, and indicate if changes were made.
References
Andrews, G., Goldberg, D. P., Krueger, R. F., Carpenter, W. T.,
Hyman, S. E., Sachdev, P., et al. (2009). Exploring the feasibility
of a meta-structure for DSM-V and ICD-11: Could it improve
utility and validity? Psychological Medicine, 39, 1993–2000.
doi:10.1017/S0033291709990250
Asmundson, G. J. G., Abramowitz, J. S., Richter, A. A., & Whedon,
M. (2010). Health anxiety: Current perspectives and future
directions. Current Psychiatry Reports, 12, 306–312. doi:10.
1007/s11920-010-0123-9
Barsky, A. J., Ettner, S. L., Horsky, J., & Bates, D. W. (2001).
Resource utilization of patients with hypochondriacal health
anxiety and somatization. Medical Care, 39, 705–715.
Barsky, A. J., & Wyshak, G. (1990). Hypochondriasis and somatosen-
sory amplification. The British Journal of Psychiatry, 157,
404–409.
Beck, A. T., Steer, R. A., & Carbin, M. G. (1988). Psychometric
properties of the beck depression inventory: Twenty-five years of
evaluation. Clinical Psychology Review, 8, 77–100. doi:10.1016/
0272-7358(88)90050-5
Blumenthal, J. A., Lett, H. S., Babyak, M. A., White, W., Smith, P.
K., Mark, D. B., et al. (2003). Depression as a risk factor for
mortality after coronary artery bypass surgery. Lancet, 362,
604–609. doi:10.1016/S0140-6736(03)14190-6
Brown, T. A., & Barlow, D. H. (2009). A proposal for a dimensional
classification system based on the shared features of the DSM-IV
anxiety and mood disorders: Implications for assessment and
treatment. Psychological Assessment, 21, 256–271. doi:10.1037/
a0016608
Burg, M. M., Benedetto, M. C., Rosenberg, R., & Soufer, R. (2003a).
Presurgical depression predicts medical morbidity 6 months
after coronary artery bypass graft surgery. Psychosomatic
Medicine, 65, 111–118.
Burg, M. M., Benedetto, M. C., & Soufer, R. (2003b). Depressive
symptoms and mortality two years after coronary artery bypass
graft surgery (CABG) in men. Psychosomatic Medicine, 65,
508–510.
256 J Behav Med (2017) 40:249–258
123
Connerney, I., Shapiro, P. A., McLaughlin, J. S., Bagiella, E., &
Sloan, R. P. (2001). Relation between depression after coronary
artery bypass surgery and 12 month outcome: A prospective
study. The Lancet, 358, 1766–1771. doi:10.1016/S0140-
6736(01)06803-9
Cosco, T. D., Doyle, F., Ward, M., & McGee, H. (2012). Latent
structure of the hospital anxiety and depression scale: A 10 year
systematic review. Journal of Psychosomatic Research, 72,
180–184. doi:10.1016/j.jpsychores.2011.06.008
Coyne, J. C., & van Sonderen, E. (2012). No further research needed:
Abandoning the hospital and anxiety depression scale (HADS).
Journal of Psychosomatic Research, 72, 173–174. doi:10.1016/j.
jpsychores.2011.12.003
Dickens, C. (2015). Depression in people with coronary heart disease:
Prognostic significance and mechanisms. Current Cardiology
Reports, 17, 640. doi:10.1007/s11886-015-0640-6
Doering, L. V., Martı´nez-Maza, O., Vredevoe, D. L., & Cowan, M. J.
(2008). Relation of depression, natural killer cell function, and
infections after coronary artery bypass in women. European
Journal of Cardiovascular Nursing: Journal of the Working
Group on Cardiovascular Nursing of the European Society of
Cardiology, 7, 52–58. doi:10.1016/j.ejcnurse.2007.07.004
Doering, L. V., Moser, D. K., Lemankiewicz, W., Luper, C., & Khan,
S. (2005). Depression, healing, and recovery from coronary
artery bypass surgery. American Journal of Critical Care: An
Official Publication, American Association of Critical-Care
Nurses, 14, 316–324.
Frasure-Smith, N., & Lespe´rance, F. (2008). Depression and anxiety
as predictors of 2 year cardiac events in patients with
stable coronary artery disease. Archives of General Psychiatry,
65, 62–71. doi:10.1001/archgenpsychiatry.2007.4
Freedland, K. E., Skala, J. A., Carney, R. M., Rubin, E. H., Lustman,
P. J., Da´vila-Roma´n, V. G., et al. (2009). Treatment of
depression after coronary artery bypass surgery: A randomized
controlled trial. Archives of General Psychiatry, 66, 387–396.
doi:10.1001/archgenpsychiatry.2009.7
Furze, G., Dumville, J., Miles, J., Irvine, K., Thompson, D., & Lewin,
R. (2009). ‘‘Prehabilitation’’ prior to CABG surgery improves
physical functioning and depressionq. International Journal of
Cardiology, 132, 51–58. doi:10.1016/j.ijcard.2008.06.001
Goldstone, T. (n.d.). How to calculate the logistic EuroSCORE.
euroSCORE.org. http://www.euroscore.org/logisticEuroSCORE.
htm. Accessed 19 April 2013
Gulliksson, M., Burell, G., Vessby, B., Lundin, L., Toss, H., &
Sva¨rdsudd, K. (2011). Randomized controlled trial of cognitive
behavioral therapy vs standard treatment to prevent recurrent
cardiovascular events in patients with coronary heart disease:
Secondary prevention in uppsala primary health care project
(SUPRIM). Archives of Internal Medicine, 171, 134–140. doi:10.
1001/archinternmed.2010.510
Hoehn-Saric, R., McLeod, D. R., Funderburk, F., & Kowalski, P.
(2004). Somatic symptoms and physiologic responses in gener-
alized anxiety disorderand panic disorder: An ambulatory
monitor study. Archives of General Psychiatry, 61, 913–921.
doi:10.1001/archpsyc.61.9.913
Katon, W. J. (2003). Clinical and health services relationships
between major depression, depressive symptoms, and general
medical illness. Biological Psychiatry, 54, 216–226.
Katon, W., Lin, E. H. B., & Kroenke, K. (2007). The association of
depression and anxiety with medical symptom burden in patients
with chronic medical illness. General Hospital Psychiatry, 29,
147–155. doi:10.1016/j.genhosppsych.2006.11.005
Lie, I., Arnesen, H., Sandvik, L., Hamilton, G., & Bunch, E. H.
(2007). Effects of a home-based intervention program on anxiety
and depression 6 months after coronary artery bypass grafting: A
randomized controlled trial. Journal of Psychosomatic Research,
62, 411–418. doi:10.1016/j.jpsychores.2006.11.010
Melzack, R. (1987). The short-form McGill pain questionnaire. Pain,
30, 191–197.
Oxlad, M., Stubberfield, J., Stuklis, R., Edwards, J., & Wade, T. D.
(2006). Psychological risk factors for increased post-operative
length of hospital stay following coronary artery bypass graft
surgery. Journal of Behavioral Medicine, 29, 179–190. doi:10.
1007/s10865-005-9043-2
Poole, L., Kidd, T., Leigh, E., Ronaldson, A., Jahangiri, M., &
Steptoe, A. (2014a). Preoperative sleep complaints are associ-
ated with poor physical recovery in the months following cardiac
surgery. Annals of Behavioral Medicine: A Publication of the
Society of Behavioral Medicine, 47, 347–357. doi:10.1007/
s12160-013-9557-8
Poole, L., Kidd, T., Leigh, E., Ronaldson, A., Jahangiri, M., &
Steptoe, A. (2014b). Depression, C-reactive protein and length of
post-operative hospital stay in coronary artery bypass graft
surgery patients. Brain, Behavior, and Immunity, 37, 115–121.
doi:10.1016/j.bbi.2013.11.008
Poole, L., Leigh, E., Kidd, T., Ronaldson, A., Jahangiri, M., &
Steptoe, A. (2014c). The combined association of depression and
socioeconomic status with length of post-operative hospital stay
following coronary artery bypass graft surgery: Data from a
prospective cohort study. Journal of Psychosomatic Research,
76, 34–40. doi:10.1016/j.jpsychores.2013.10.019
Prenoveau, J. M., Zinbarg, R. E., Craske, M. G., Mineka, S., Griffith, J.
W., & Epstein, A. M. (2010). Testing a hierarchical model of
anxiety and depression in adolescents: A tri-level model. Journal of
Anxiety Disorders, 24, 334–344. doi:10.1016/j.janxdis.2010.01.006
Rieckmann, N., Burg, M. M., Kronish, I. M., Chaplin, W. F.,
Schwartz, J. E., & Davidson, K. W. (2011). Aspirin adherence,
depression and one-year prognosis after acute coronary syn-
drome. Psychotherapy and Psychosomatics, 80, 316–318.
doi:10.1159/000323168
Rieckmann, N., Gerin, W., Kronish, I. M., Burg, M. M., Chaplin, W.
F., Kong, G., et al. (2006). Course of depressive symptoms and
medication adherence after acute coronary syndromes: An
electronic medication monitoring study. Journal of the American
College of Cardiology, 48, 2218–2222. doi:10.1016/j.jacc.2006.
07.063
Rollman, B. L., Belnap, B. H., LeMenager, M. S., Mazumdar, S.,
Houck, P. R., Counihan, P. J., et al. (2009). Telephone-delivered
collaborative care for treating post-CABG depression: A
randomized controlled trial. JAMA: The Journal of the American
Medical Association, 302, 2095–2103. doi:10.1001/jama.2009.
1670
Rollman, B. L., & Herbeck Belnap, B. (2011). The bypassing the
blues trial: Collaborative care for post-CABG depression and
implications for future research. Cleveland Clinic Journal of
Medicine, 78, S4–S12. doi:10.3949/ccjm.78.s1.01
Roques, F., Michel, P., Goldstone, A. R., & Nashef, S. A. M. (2003).
The logistic EuroSCORE. European Heart Journal, 24,
881–882.
Rosenbloom, J. I., Wellenius, G. A., Mukamal, K. J., & Mittleman,
M. A. (2009). Self-reported anxiety and the risk of clinical
events and atherosclerotic progression among patients with
coronary artery bypass grafts (CABG). American Heart Journal,
158, 867–873. doi:10.1016/j.ahj.2009.08.019
Schroter, S., & Lamping, D. L. (2004). Coronary revascularisation
outcome questionnaire (CROQ): Development and validation of
a new, patient based measure of outcome in coronary bypass
surgery and angioplasty. British Medical Journal, 90, 1460.
Sebregts, E. H. W. J., Falger, P. R. J., Appels, A., Kester, A. D. M., &
Ba¨r, F. W. H. M. (2005). Psychological effects of a short
J Behav Med (2017) 40:249–258 257
123
behavior modification program in patients with acute myocardial
infarction or coronary artery bypass grafting. A randomized
controlled trial. Journal of Psychosomatic Research, 58,
417–424. doi:10.1016/j.jpsychores.2004.02.021
Siu, A. L., US Preventive Services Task Force (USPSTF), Bibbins-
Domingo, K., Grossman, D. C., Baumann, L. C., Davidson, K.
W., et al. (2016). Screening for depression in adults: US
preventive services task force recommendation statement.
JAMA, 315, 380–387. doi:10.1001/jama.2015.18392
Stenman, M., Holzmann, M. J., & Sartipy, U. (2014). Relation of
major depression to survival after coronary artery bypass
grafting. The American Journal of Cardiology, 114, 698–703.
doi:10.1016/j.amjcard.2014.05.058
Steptoe, A., Poole, L., Ronaldson, A., Kidd, T., Leigh, E., & Jahangiri,
M. (2015). Depression 1 year after CABG is predicted by acute
inflammatory responses. Journal of the American College of
Cardiology, 65, 1710–1711. doi:10.1016/j.jacc.2014.12.068
Sunderland, M., Newby, J. M., & Andrews, G. (2013). Health anxiety
in Australia: Prevalence, comorbidity, disability and service use.
The British Journal of Psychiatry: The Journal of Mental
Science, 202, 56–61. doi:10.1192/bjp.bp.111.103960
Sze´kely, A., Balog, P., Benko¨, E., Breuer, T., Sze´kely, J., Kertai, M.
D., et al. (2007). Anxiety predicts mortality and morbidity after
coronary artery and valve surgery–a 4 year follow-up study.
Psychosomatic Medicine, 69, 625–631. doi:10.1097/PSY.
0b013e31814b8c0f
Tully, P. J., Baker, R. A., & Knight, J. L. (2008a). Anxiety and
depression as risk factors for mortality after coronary artery
bypass surgery. Journal of Psychosomatic Research, 64,
285–290. doi:10.1016/j.jpsychores.2007.09.007
Tully, P. J., Baker, R. A., Turnbull, D., & Winefield, H. (2008b). The
role of depression and anxiety symptoms in hospital readmis-
sions after cardiac surgery. Journal of Behavioral Medicine, 31,
281–290. doi:10.1007/s10865-008-9153-8
Tully, P. J., Baker, R. A., Turnbull, D. A., Winefield, H. R., & Knight,
J. L. (2009). Negative emotions and quality of life six months
after cardiac surgery: The dominant role of depression not
anxiety symptoms. Journal of Behavioral Medicine, 32,
510–522. doi:10.1007/s10865-009-9225-4
Tully, P. J., Winefield, H. R., Baker, R. A., Denollet, J., Pedersen, S.
S., Wittert, G. A., et al. (2015). Depression, anxiety and major
adverse cardiovascular and cerebrovascular events in patients
following coronary artery bypass graft surgery: A five year
longitudinal cohort study. BioPsychoSocial Medicine, 9, 14.
doi:10.1186/s13030-015-0041-5
Tyrer, P., Cooper, S., Salkovskis, P., Tyrer, H., Crawford, M., Byford,
S., et al. (2014). Clinical and cost-effectiveness of cognitive
behaviour therapy for health anxiety in medical patients: A
multicentre randomised controlled trial. Lancet (London, Eng-
land), 383, 219–225. doi:10.1016/S0140-6736(13)61905-4
Watson, D. (2009). Differentiating the mood and anxiety disorders: A
quadripartite model. Annual Review of Clinical Psychology, 5,
221–247. doi:10.1146/annurev.clinpsy.032408.153510
Wellenius, G. A., Mukamal, K. J., Kulshreshtha, A., Asonganyi, S., &
Mittleman, M. A. (2008). Depressive symptoms and the risk of
atherosclerotic progression among patients with coronary artery
bypass grafts. Circulation, 117, 2313–2319. doi:10.1161/
CIRCULATIONAHA.107.741058
Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and
depression scale. Acta Psychiatrica Scandnavica, 67, 361–370.
258 J Behav Med (2017) 40:249–258
123
